Ignite Creation Date:
2024-05-05 @ 5:19 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00432211
Status:
UNKNOWN
Last Update Posted:
2009-02-04
First Post:
2007-02-06
Brief Title:
Juvista Avotermin in the Prevention or Improvement of Scar Appearance Following Scar Revision Surgery
Sponsor:
Renovo
Organization:
Renovo
Study Overview
Official Title:
A Double Blind Placebo Controlled Randomised Trial to Investigate the Efficacy of Juvista Avotermin in the Prevention or Improvement of Scar Appearance Following Scar Revision Surgery
Status:
UNKNOWN
Status Verified Date:
2009-02
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is being undertaken to investigate the efficacy and safety of Juvista given as an intradermal injection of 200ng100µl per linear centimetre of wound margin in the prevention or improvement of scar appearance when administered intradermally to approximated wound margins following surgical scar revision
In addition this study will compare the scar revision techniques of complete excision excision of the entire scar during one surgical procedure and staged excision excision of the outmost segments and central core separately
In addition this study will compare the scar revision techniques of complete excision excision of the entire scar during one surgical procedure and staged excision excision of the outmost segments and central core separately
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None